Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 636

1.

Risk of leukemia following treatment for non-Hodgkin's lymphoma.

Travis LB, Curtis RE, Stovall M, Holowaty EJ, van Leeuwen FE, Glimelius B, Lynch CF, Hagenbeek A, Li CY, Banks PM, et al.

J Natl Cancer Inst. 1994 Oct 5;86(19):1450-7.

PMID:
8089863
[PubMed - indexed for MEDLINE]
2.

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.

Travis LB, Curtis RE, Glimelius B, Holowaty EJ, Van Leeuwen FE, Lynch CF, Hagenbeek A, Stovall M, Banks PM, Adami J, et al.

J Natl Cancer Inst. 1995 Apr 5;87(7):524-30.

PMID:
7707439
[PubMed - indexed for MEDLINE]
3.

Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.

Travis LB, Weeks J, Curtis RE, Chaffey JT, Stovall M, Banks PM, Boice JD Jr.

J Clin Oncol. 1996 Feb;14(2):565-71.

PMID:
8636772
[PubMed - indexed for MEDLINE]
4.

Treatment-associated leukemia following testicular cancer.

Travis LB, Andersson M, Gospodarowicz M, van Leeuwen FE, Bergfeldt K, Lynch CF, Curtis RE, Kohler BA, Wiklund T, Storm H, Holowaty E, Hall P, Pukkala E, Sleijfer DT, Clarke EA, Boice JD Jr, Stovall M, Gilbert E.

J Natl Cancer Inst. 2000 Jul 19;92(14):1165-71.

PMID:
10904090
[PubMed - indexed for MEDLINE]
Free Article
5.

Incidence of second cancers in patients treated for Hodgkin's disease.

Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, et al.

J Natl Cancer Inst. 1995 May 17;87(10):732-41.

PMID:
7563150
[PubMed - indexed for MEDLINE]
6.

The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.

Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.

Haematologica. 1998 Sep;83(9):812-23.

PMID:
9825578
[PubMed - indexed for MEDLINE]
Free Article
7.

Relationship of leukemia risk to radiation dose following cancer of the uterine corpus.

Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Holowaty E, Karjalainen S, Langmark F, Nasca PC, Schwartz AG, Schymura MJ, et al.

J Natl Cancer Inst. 1994 Sep 7;86(17):1315-24.

PMID:
8064889
[PubMed - indexed for MEDLINE]
8.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ.

Blood. 2003 Mar 1;101(5):2015-23. Epub 2002 Oct 10.

PMID:
12393427
[PubMed - indexed for MEDLINE]
Free Article
9.

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr, Burgers JM, Somers R.

J Natl Cancer Inst. 1995 Oct 18;87(20):1530-7.

PMID:
7563187
[PubMed - indexed for MEDLINE]
10.

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.

Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E.

J Natl Cancer Inst. 2002 Feb 6;94(3):182-92.

PMID:
11830608
[PubMed - indexed for MEDLINE]
Free Article
11.

Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.

Cimino G, Papa G, Tura S, Mazza P, Rossi Ferrini PL, Bosi A, Amadori S, Lo Coco F, D'Arcangelo E, Giannarelli D, et al.

J Clin Oncol. 1991 Mar;9(3):432-7.

PMID:
1999712
[PubMed - indexed for MEDLINE]
12.

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH.

J Natl Cancer Inst. 1997 Feb 19;89(4):301-7.

PMID:
9048834
[PubMed - indexed for MEDLINE]
Free Article
13.

Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.

Greene MH, Young RC, Merrill JM, DeVita VT.

Cancer Res. 1983 Apr;43(4):1891-8.

PMID:
6572558
[PubMed - indexed for MEDLINE]
Free Article
14.

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.

van den Belt-Dusebout AW, Aleman BM, Besseling G, de Bruin ML, Hauptmann M, van 't Veer MB, de Wit R, Ribot JG, Noordijk EM, Kerst JM, Gietema JA, van Leeuwen FE.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1420-9. doi: 10.1016/j.ijrobp.2009.01.073.

PMID:
19931732
[PubMed - indexed for MEDLINE]
15.

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.

van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, Hagenbeek A, Noyon R, van Kerkhoff EH, Pinedo HM, Somers R.

J Clin Oncol. 1994 May;12(5):1063-73.

PMID:
8164031
[PubMed - indexed for MEDLINE]
16.

Second cancers among long-term survivors of non-Hodgkin's lymphoma.

Travis LB, Curtis RE, Glimelius B, Holowaty E, Van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P, et al.

J Natl Cancer Inst. 1993 Dec 1;85(23):1932-7.

PMID:
8230284
[PubMed - indexed for MEDLINE]
17.

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS.

J Natl Cancer Inst. 2003 Jul 2;95(13):971-80.

PMID:
12837833
[PubMed - indexed for MEDLINE]
Free Article
18.

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ.

Blood. 1996 May 1;87(9):3625-32.

PMID:
8611686
[PubMed - indexed for MEDLINE]
Free Article
19.

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.

Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C.

J Cancer Res Clin Oncol. 1998;124(3-4):207-14. Review.

PMID:
9619748
[PubMed - indexed for MEDLINE]
20.

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R.

J Clin Oncol. 1994 Feb;12(2):312-25.

PMID:
8113838
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk